USD 165.19 million
Report ID:
SQMIG35G2212 |
Region:
Global |
Published Date: February, 2025
Pages:
157
|Tables:
63
|Figures:
75
Lacrimal Devices Market size was valued at USD 165.19 million in 2023 and is poised to grow from USD 171.47 million in 2024 to USD 231.08 million by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).
The lacrimal devices market is currently witnessing significant growth due to increasing awareness and diagnosis of ophthalmic conditions across various age groups.
As eye-related disorders become more prevalent, the demand for advanced lacrimal devices, such as punctal plugs, lacrimal stents, and irrigation systems, continues to rise. Additionally, advancements in technology and surgical techniques have led to improved patient outcomes, further driving market expansion.
Moreover, the aging population and the associated increase in age-related eye conditions contribute to sustained growth in this market. Healthcare providers and manufacturers are focusing on developing innovative solutions to address the evolving needs of patients with lacrimal disorders, aiming to enhance the quality of care and patient comfort. This market is also influenced by regulatory factors and reimbursement policies, which play a crucial role in shaping market dynamics.
Overall, the lacrimal devices market exhibits promising opportunities for companies operating in the ophthalmic devices industry, with a growing emphasis on patient-centric solutions and improved treatment outcomes.
US Lacrimal Devices Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 165.19 million
Largest Segment
Stents And Tubes
Fastest Growth
Stents And Tubes
Growth Rate
3.8% CAGR
To get more reports on the above market click here to Buy The Report
Global Lacrimal Devices Market is segmented by Product, Application, End-use and region. Based on Product, the market is segmented into Intubation Sets, Stents and Tubes, Cannula and Spatula and Dilators. Based on Application, the market is segmented into Glaucoma, Dry Eye, Lacrimal Gland Inflammation, Epiphora and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Care Centers (ACC). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Stents and Tubes currently dominate the market in the medical devices industry. This dominance can be attributed to their widespread use in various medical procedures, including cardiovascular interventions and the management of various anatomical obstructions. Stents and tubes serve critical roles in ensuring open pathways within the body, making them indispensable in many medical contexts. Their versatile applications across multiple medical disciplines contribute to their dominant position in the market.
However, Dilators are experiencing rapid growth within the medical devices market due to several key factors. Firstly, they are vital instruments in minimally invasive procedures, such as endoscopy and urology, which are becoming increasingly popular due to their reduced patient trauma and quicker recovery times. Secondly, advancements in medical technology have led to the development of innovative dilators with enhanced precision and safety features, appealing to both healthcare professionals and patients. As these minimally invasive techniques gain wider acceptance, the demand for dilators is expected to continue its robust growth trajectory.
Glaucoma remains a dominating application in the ophthalmic devices market. This condition is a leading cause of irreversible vision loss worldwide, necessitating ongoing demand for diagnostic and treatment devices. The dominance of glaucoma in the market is due to its prevalence in aging populations and the importance of early detection and management to prevent vision impairment.
However, Dry eye is emerging as the fastest-growing application in the market. This growth is primarily attributed to changing lifestyles, increased screen time, and environmental factors, all contributing to a rising incidence of dry eye syndrome. Innovations in artificial tears, diagnostic tools, and treatments have fueled this growth as patients seek relief from dry eye symptoms.
To get detailed analysis on other segments, Request For Free Sample Report
North America, specifically the United States and Canada, traditionally dominates the lacrimal devices market. This dominance is due to the presence of high healthcare expenditure, advanced healthcare infrastructure, and a large population of patients with eye-related disorders. Furthermore, the region benefits from robust research and development activities, fostering innovation in the field of ophthalmic devices.
However, the Asia Pacific region, including countries like China, India, and Japan, is emerging as the fastest-growing market for lacrimal devices. This growth is primarily driven by increasing healthcare awareness, a rising geriatric population, and improving healthcare access in developing economies. Additionally, the adoption of advanced medical technologies and a surge in eye-related conditions contribute to the rapid expansion of the market in this region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Incidence of Eye Disorders
Regulatory Challenges and Approval Delays
Request Free Customization of this report to help us to meet your business objectives.
The lacrimal devices market exhibits a competitive landscape characterized by the presence of several established and emerging players. Market competitiveness is primarily driven by continuous product innovation, research and development investments, and strategic partnerships. Companies within this sector focus on expanding their product portfolios to cater to a wide range of ophthalmic disorders.
Additionally, the market witness's competition in terms of pricing strategies and geographical expansion to gain a competitive edge. As the demand for advanced lacrimal devices grows, competition intensifies, compelling companies to enhance their market presence and offer differentiated solutions to healthcare providers and patients.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to global lacrimal devices market analysis, the market analysis reveals a landscape characterized by steady growth driven by various factors. Increasing awareness about eye health and the rising incidence of lacrimal system disorders across diverse age groups are driving the demand for advanced diagnostic and treatment solutions. Technological advancements and surgical innovations further contribute to improved patient outcomes, fostering market expansion. Additionally, the aging global population and its susceptibility to age-related eye conditions provide a sustained market base. However, the market is not without challenges; stringent regulatory processes and approval delays can hinder swift product introductions.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 165.19 million |
Market size value in 2032 | USD 231.08 million |
Growth Rate | 3.8% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Lacrimal Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Lacrimal Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Lacrimal Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Lacrimal Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Lacrimal Devices Market size was valued at USD 217.17 Million in 2023 and is poised to grow from USD 235.63 Million in 2024 to USD 452.55 Million by 2032, growing at a CAGR of 8.50% during the forecast period (2025-2032).
The lacrimal devices market exhibits a competitive landscape characterized by the presence of several established and emerging players. Market competitiveness is primarily driven by continuous product innovation, research and development investments, and strategic partnerships. Companies within this sector focus on expanding their product portfolios to cater to a wide range of ophthalmic disorders. 'FCI Ophthalmic (France)', 'Kaneka Corporation (Japan)', 'Lacrimedics, Inc. (US)', 'Cook Group (US)', 'BVI (UK)', 'Rumex International (US)', 'Bess Medical Technology GmbH (Germany)', 'Alcon (Switzerland)', 'Bausch and Lomb Incorporated (US)', 'BraunMelsungen AG (Germany)', 'OASIS Medical, Inc. (US)', 'Beaver-Visitec International (US)', 'FC Optics Ltd. (Israel)', 'D.O.R.C. Dutch Ophthalmic Research Center (Netherlands)', 'OptiMedica Corporation (US)', 'MicroSurgical Technology (US)', 'Diamatrix Ltd. (UK)', 'FCI S.A.S. (France)', 'Novartis AG (Switzerland)', 'Eye Kon Medical, Inc. (US)'
The primary driving force behind the lacrimal devices market is the escalating incidence of eye disorders globally. Factors such as aging populations, changing lifestyles, and increased screen time contribute to conditions like dry eye syndrome and other lacrimal system disorders. Consequently, there is a growing demand for lacrimal devices that aid in the diagnosis and treatment of these conditions, propelling market growth.
Shift Towards Minimally Invasive Procedures : A significant market trend in lacrimal devices is the increasing preference for minimally invasive procedures. Patients and healthcare providers are opting for less invasive techniques for lacrimal system disorders, as they offer quicker recovery times, reduced postoperative complications, and improved patient comfort. This trend is driving innovation in the development of minimally invasive lacrimal devices, such as microendoscopes and specialized catheters, to address these evolving preferences in patient care.
North America, specifically the United States and Canada, traditionally dominates the lacrimal devices market. This dominance is due to the presence of high healthcare expenditure, advanced healthcare infrastructure, and a large population of patients with eye-related disorders. Furthermore, the region benefits from robust research and development activities, fostering innovation in the field of ophthalmic devices.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35G2212
[email protected]
USA +1 351-333-4748